ConductScience.org, home

Trial · NCT07877974

Efficacy of Gastrocnemius Plane Block for Foot and Ankle Surgery

NCT07877974, Not applicable, Recruiting, Cairo University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Efficacy of Gastrocnemius Plane Block for Foot and Ankle Surgery. Trials, record NCT07877974. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07877974

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Efficacy of Gastrocnemius Plane Block for Foot and Ankle Surgery
NCT number
NCT07877974
Status
Recruiting
Phases
Not applicable
Enrollment
40 participants, estimated
Lead sponsor
Cairo University
Conditions
Gastrocnemius, Ankle Surgery, Foot Surgery, Postoperative Analgesia
Interventions
GPB Group : This group will receive ultrasound-guided Gastrocnemius plane block with 30 mL bupivacaine (0.25%), SAB
First posted
2026-10-16
Last updated
2026-10-16

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTime to first postoperative analgesic request24 hoursTime to first postoperative analgesic request
SecondaryVisual analogue pain score (VAS)24 hoursVisual analogue pain score (VAS) at rest (static), and on movement (dynamic) at 2, 4, 6, 12, 18, and 24 hours postoperatively
SecondaryPostoperative assessment of sensory and motor function24 hours
Assessment of sensory block: Sensory block will be assessed using a pinprick test with a blunt 22-gauge needle along dermatomes relevant to the surgery. The degree of sensory loss will be graded as follows: * Grade 0: Normal sensation to pinprick * Grade 1: Decreased but present sensation to pinprick (hypoalgesia) * Grade 2: Complete loss of sensation to pinprick (analgesia)
SecondaryTime to first postoperative analgesic request24 hoursTime to first postoperative analgesic request
SecondaryTotal morphine requirements24 hoursTotal morphine requirements 24 hours postoperatively.
SecondaryTime to early mobilization24 hoursTime to early mobilization: First bedtime helps to judge the effect of the nerve block
SecondaryIncidence of complications related to the blocks24 hoursIncidence of complications related to the blocks as hematoma or Toxicity
SecondaryIncidence of postoperative nausea and vomiting24 hoursIncidence of postoperative nausea and vomiting
SecondaryPostoperative assessment of motor function24 hours
Assessment of motor block: using the Modified Bromage score, which will be evaluated to assess the motor block as follows: * Bromage 0: full flexion of the knee and feet. * Bromage 1: just able to move the knee * Bromage 2: able to move the feet. * Bromage 3: unable to move the knees and feet

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07877974

GET https://conductscience.org/api/trials/v1/NCT07877974/registered